Data gathered: May 30
AI Stock Analysis - TransMedics Group (TMDX)
Analysis generated September 28, 2024. Powered by Chat GPT.
TransMedics Group, Inc. (NASDAQ: TMDX) is an innovative medical technology company specializing in organ transplant systems. Their flagship product, the Organ Care System (OCS), revolutionizes organ preservation, making it possible to monitor and maintain organs in a near-physiologic, functioning state outside the body. The company's breakthrough technology aims to improve the outcomes of organ transplantation, targeting significant unmet needs in the healthcare industry.
Stock Alerts - TransMedics Group (TMDX)
 |
TransMedics Group | May 30 Insider Alert: Basile Edward M is selling shares |
|
TransMedics Group | May 24 Insider Alert: Weill David is selling shares |
|
TransMedics Group | May 14 Insider Alert: Basile Edward M is selling shares |
|
TransMedics Group | May 13 Business Outlook among employees is up by 10.6% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for TransMedics Group
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 40 | Sign up | Sign up | Sign up |
| Sentiment | 94 | Sign up | Sign up | Sign up |
| Webpage traffic | 55,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 1,984 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 18 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,205 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,540 | Sign up | Sign up | Sign up |
| Twitter Mentions | 425 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 869 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 47 | Sign up | Sign up | Sign up |
| Linkedin Employees | 485 | Sign up | Sign up | Sign up |
About TransMedics Group
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
| Price | $127.00 |
| Target Price | Sign up |
| Volume | 165,300 |
| Market Cap | $4.35B |
| Year Range | $56.73 - $165 |
| Dividend Yield | 0% |
| PE Ratio | 91.22 |
| Analyst Rating | 75% buy |
| Industry | Medical Devices |
In the news
Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law FirmMay 27 - Finnhub |
|
 |
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.May 26 - ETF Daily News |
|
TransMedics Group, Inc. (NASDAQ:TMDX) Receives $126.70 Consensus PT from BrokeragesMay 25 - ETF Daily News |
 |
Assessing TransMedics Group And Two Other Stocks That Might Be Trading Below Estimated ValueMay 21 - Yahoo |
|
Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy?May 15 - Yahoo |
|
What Makes TransMedics (TMDX) a New Buy StockMay 15 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 144M | 55M | 88M | 26M | 0 | 0.700 |
| Q4 '24 | 122M | 50M | 72M | 6.9M | 16M | 0.190 |
| Q3 '24 | 109M | 48M | 61M | 4.2M | 13M | 0.120 |
| Q2 '24 | 114M | 45M | 69M | 12M | 17M | 0.350 |
| Q1 '24 | 97M | 37M | 60M | 12M | 17M | 0.350 |
Insider Transactions View All
| Basile Edward M filed to sell 2,866 shares at $126.5. May 29 '25 |
| Weill David filed to sell 12,134 shares at $123.9. May 23 '25 |
| Basile Edward M filed to sell 732 shares at $115.6. May 13 '25 |
| Khayal Tamer I filed to sell 36,042 shares at $76.4. March 5 '25 |
| Khayal Tamer I filed to sell 20,843 shares at $80.1. January 10 '25 |
Similar companies
Read more about TransMedics Group (TMDX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of TransMedics Group?
The Market Cap of TransMedics Group is $4.35B.
What is TransMedics Group's PE Ratio?
As of today, TransMedics Group's PE (Price to Earnings) ratio is 91.22.
What is the current stock price of TransMedics Group?
Currently, the price of one share of TransMedics Group stock is $127.00.
How can I analyze the TMDX stock price chart for investment decisions?
The TMDX stock price chart above provides a comprehensive visual representation of TransMedics Group's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling TransMedics Group shares. Our platform offers an up-to-date TMDX stock price chart, along with technical data analysis and alternative data insights.
Does TMDX offer dividends to its shareholders?
As of our latest update, TransMedics Group (TMDX) does not offer dividends to its shareholders. Investors interested in TransMedics Group should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of TransMedics Group?
Some of the similar stocks of TransMedics Group are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.